Free Trial
ASX:M7T

Mach7 Technologies (M7T) Stock Price, News & Analysis

Mach7 Technologies logo

About Mach7 Technologies Stock (ASX:M7T)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
272,627 shs
Average Volume
N/A
Market Capitalization
$98.91 million
P/E Ratio
N/A
Dividend Yield
3.37%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe and internationally. The company offers enterprise diagnostic viewing, which includes eUnity zero-footprint viewer that connects departmental imaging from across the enterprise to deliver studies to care providers via the EMR. It also offers enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. In addition, the company provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as implementation, training, support, and maintenance services, as well as project management. Mach7 Technologies Limited was incorporated in 1977 and is headquartered in South Burlington, Vermont.

Remove Ads
Receive M7T Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mach7 Technologies and its competitors with MarketBeat's FREE daily newsletter.

M7T Stock News Headlines

This almost killed Elon Musk (chilling details emerge)
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
Morgans Sticks to Their Buy Rating for Mach7 Technologies Ltd. (TDMMF)
See More Headlines

M7T Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Mach7 Technologies investors own include Farfetch (FTCH), Eton Pharmaceuticals (ETON), Eqonex (EQOS), Denison Mines (DNN), Denali Therapeutics (DNLI), Carbios SAS (COOSF) and CleanSpark (CLSK).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
ASX:M7T
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-23.2
Net Income
$-7,970,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$29.13 million
Price / Cash Flow
4.17
Book Value
A$0.21 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$98.91 million
Optionable
Not Optionable
Beta
1.69
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (ASX:M7T) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners